Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis

Kidney International

Volumn 49, Issue 2, 1996, Pages 335-343

  Brandt, John ^b   Pippin, Jeffrey ^b   Schulze, Matthias ^b   Hänsch, Gertrud M ^b   Alpers, Charles E ^b   Johnson, Richard J ^b   Gordon, Katherine ^b   Couser, William G ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 4; COMPLEMENT MEMBRANE ATTACK COMPLEX; THYMOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; MACROPHAGE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIOLYSIS; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; THROMBOCYTE;

EID: 0030045641     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.50     Document Type: Article

References (51)

1. JOHNSON RJ: The glomerular response to injury: Progression or resolution? (Nephrology Forum) Kidney Int 45:1769-1782, 1984
2. ALPERS CE, HUDKINS KL, GOWN AM, JOHNSON RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1144, 1992
3. ENG E, FLOEGE J, YOUNG BA, ALPERS CE, COUSER WG, JOHNSON RJ: Is mesangial cell proliferation required for extracellular matrix expansion in glomerular disease? Contrib Nephrol 107:156-162, 1994
4. YAMAMOTO T, WILSON CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. J Immunol 32: 514-525, 1987
5. IIDA H, SEIFERT R, ALPERS CE, GROWNWALD RGK, PHILLIPS PE, PRITZL P, GORDON K, GOWN AM, ROSS R, BOWEN-POPE DF, JOHNSON RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferate nephritis in the rat. Proc Natl Acad Sci USA 88:6560-6564, 1991
6. FLOEGE J, ENG E, LINDER V, ALPERS CE, YOUNG BA, REIDY MA, JOHNSON RJ: Rat glomerular mesangial cells synthesize basic FGF: Release, upregulated synthesis and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 90:2362-2369, 1942
7. FLOEGE J, ENG E, YOUNG BA, ALPERS CE, BARRETT TB, BOWEN-POPE DF, JOHNSON RJ: Infusion of PDGF or basic FGF induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962, 1993
8. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462, 1990
9. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
10. YAMAMOTO T, WILSON CB: Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 138:3758-3765, 1987
11. JOHNSON RJ, PRITZL P, IIDA H, ALPERS CE: Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol 138:313-321, 1990
12. COUSER WG, JOHNSON RJ, YOUNG BA, YEH CG, TOTH CA, RUDOLPH AR: The effects of soluble recombinant CR1 on complement-mediated experimental glomerulonephritis. J.Am Soc Nephrol 5:1888-1894, 1995
13. FLOEGE J, JOHNSON RJ, GORDON K, IIDA H, PRITZL P, YOSHIMURA A, CAMPBELL C, ALPERS CE, COUSER WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-488, 1991
14. COUSER WG: The pathogenesis of glomerulonephritis. Kidney Int 44(Suppl 42):S19-S26, 1993
15. ADLER S, BAKER PJ, JOHNSON RJ, OCHI RF, PRITZL P, COUSER WG: Complement membrane attack complex stimulates production of oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77:762-777, 1986
16. LOVETT DH, HÄNSCH G-M, GOPPELT M, RESCH K, GEMSA D: Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol 138:2473-2480, 1987
17. SCHONERMARK M, DEPPISCH R, RIEDASCH G, ROTHER K. HANSCH GM: Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol 96:331-337, 1991
18. NEILSON RA, JENSEN J, GIGLI I, TAMURA N: Methods for the separation, purification, and measurement of nine components of hemolytic complement in guinea pig serum. Immunochemistry 3:111-135, 1966
19. VROON DH, SCHULTZ DR, ZARCO RM: The separation of nine components and two inactivators of components in human serum. Immunochemistry 7:43-61, 1970
20. SCHULZE M, BAKER PJ, PERKINSON DT, JOHNSON RJ, OCHI RF, STAHL RAK, COUSER WG: Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 35:60-68, 1989
21. BRENNEIS H, SCHMIDT A, BLAAS-MAUTNER P, WÖRNER I, LUDWIG R, HÄNSCH GM: Chemotaxis of polymorphonuclear neutrophils (PMN) in patients suffering from recurrent infection. Eur J Clin Invest 23:693-698, 1993
22. KURKI P, VANDERLAAN M, DOLBEARE F, GRAY J, TAN EM: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166:209-219, 1986
23. DIJKSTRA CD, DOPP EA, JOLINO P, KRAAL G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54(3):589-599, 1985
24. SEKIYA S, GOTOH S, YAMASHITA T, WATANABE T, SAITOH S, SENDO F: Selective depletion of rat neutrophils by in vivo administration of a monoclonal antibody. J Leukocyte Biol 46:96-102, 1989
25. BAGCHUS WM, JEUNINK MF, ROZING J, ELEMA JD: A monoclonal antibody against rat platelets. I. Tissue distribution in vitro and in vivo. Clin Exp Immunol 75:317-323, 1989
26. SKALLI O, ROPRAZ P, TRZECIAK A, BENZONANA G, GILLESSEN D, GABBIANI G: A monoclonal antibody against a-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796, 1986
27. YOUNG BA, JOHNSON RJ, ALPERS C, ENG E, GORDON K, FLOEGE J, COUSER WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
28. SCHULZE M, PRUCHNO CJ, BURNS M, BAKER PJ, JOHNSON RJ, COUSER WG: Glomerular localization of C3c indicates on-going immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol 142:179-187, 1993
29. KERJASCHKI D, SCHULZE M, BINDER S, KAIN R, OJHA PP, SUSANI M, HORVAT R, BAKER PJ, COUSER WG: Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 143:546-552, 1989
30. BRADLEY GM, BENSON ES: Examination of the urine, in Todd-Sanford Clinical Diagnosis by Laboratory Methods, edited by DAVIDSON I, HENRY JB, (15th ed), WB Saunders, Philadelphia, 1974, pp 74-75
31. WALLENSTEIJN S, ZUCKER CL, FLEISS JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
32. JOHNSON RJ, IIDA H, ALPERS CE, MAJESKY MW, SCHWARTZ SM, PRITZL P, GORDON K, GOWN AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 87:847-858, 1991
33. LEENAERTS PL, STAD RK, HALL BM, VAN DAMME BJ, VANRENTERGHEM Y, DAHA MR: Hereditary C6 deficiency in a strain of PVG/c rats. Clin Exp Immunol 97:478-484, 1994
34. BRAUER RB, BALDWIN WM, DAHA MR, PRUITT SK, SANFILIPPO F: Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 151:7240-7248, 1993
35. BRAUER RB, BALDWIN WM, IBRAHIM S, SANFILIPPO F: The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Transplant 59:288-293, 1995
36. BAKER PJ, ADLER S, YANG Y, COUSER WG: Complement activation by heat-killed human kidney cells: Formation, activity and stabilization of cell-bound C3 convertases. J Immunol 133:877-880, 1984
37. QUIGG RJ, CYBULSKY AV, SALANT DJ: Effect of nephritogenic antibody on complement regulation in cultured rat glomerular epithelial cells. J Immunol 147:838-845, 1991
38. HANSCH GM, SCHIEREN G, WAGNER C, SCHONERMARK M: Immune damage to the mesangium: Antibody- and complement-mediated stimulation and destruction of mesangial cells. J Am Soc Nephrol 2(Suppl 10):S139-S143, 1992
39. WAGNER C, BRAUNGER M, BEER M, ROTHER K, HÄNSCH GM: Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephrol 2:51-56, 1994
40. TORBOHM I, SCHONERMARK M, WINGEN A-M, BERGER B, ROTHER K, HÄNSCH GM: C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int 37:1098-1104, 1990
41. NUNEZ D, CHARRIAUT-MARLANGUE C, BAREL M, BENVENISTE J, FRADE R: Activation of human platelets through gp140, the C3d/EBV receptor (CR2). Eur J Immunol 17:515-520, 1987
42. COSGROVE LJ, D'APICE AJF, HADDAD A, PEDERSEN J, MCKENZIE IF: CR3 receptor on platelets and its role in the prostaglandin metabolic pathway. Immunol Cell Biol 65:453-460, 1987
43. VIK DP, FEARON DT: Cellular distribution of complement receptor type 4 (CR4): Expression on human platelets. J Immunol 138:254-258, 1987
44. MEUER S, ECKER U, HADDING U, BITTER-SUERMANN D: Platelet-serotonin release by C3a and C5a: Two independent pathways of activation. J Immunol 126:1506-1509, 1981
45. WIEDMER T, ESMON CT, SIMS PJ: Complement proteins C5b-9 stimulates procoagulant activity through platelet prothrombinase. Blood 68:875-880, 1986
46. HALPERIN JA, TARATUSKA A, NICHOLSON-WELLER A: Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. J Clin Invest 91:1974-1978, 1993
47. ARNAOLIT MA: Cell adhesion molecules in inflammation and thrombosis: Status and prospects. Am J Kidney Dis 21:72-76, 1993
48. NISHIKAWA K, Guo Y-J, MIYASAKA M, TAMATANI T, COLLINS AB, SY MS, McCLUSKEY RT, ANDRES G: Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen I prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med 177:667-677, 1993
49. COUSER WG, SCHULZE M, PRUCHNO CJ: Role of C5b-9 in experimental membranous nephropathy. Nephrol Dial Transplant 1:25-31, 1992
50. FALK RJ, DALMASSO AP, KIM Y, TSAI CH, SCHEINMAN JI, GEWURZ H, MICHAEL AF: Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest 72:560-573, 1983
51. RAUTERBERG EW, LIEBERKNECHT HM, WINGEN AM, RITZ E: Complement membrane attack (MAC) in idiopathic IgA glomerulonephritis. Kidney Int 31:820-829, 1987